ETFs To Buy On Solid Biotech Stock Earnings [Celgene Corporation, Biogen Idec Inc, Alexion Pharmaceuticals, Inc., Amgen, Inc.]

biotechBiotech stocks and the related ETFs have been the star performers this year despite some temporary glitches and rough trading in between. Encouraging industry trends, increasing merger and acquisition activities, expansion
NASDAQ:BIB October 29, 2014 5:13pm

Quick Investor Guide To Biotech ETFs [iShares NASDAQ Biotechnology Index (ETF), SPDR S&P Biotech (ETF)]

biotechMergers and acquisitions (M&As) continue to play a major role in the biotech sector and are not showing any signs of slowing down. Biotech companies have always attracted a lot of interest especially from their pharma counterparts
NASDAQ:IBB October 3, 2014 3:09pm

ETF Impact On Biotech Earnings [Celgene Corporation, Alexion Pharmaceuticals, Inc., Amgen, Inc., Biogen Idec Inc]

biotechnologyThe Q2 earnings season has so far been great for biotech companies with most of them giving solid quarterly updates. Biotech giant Gilead Sciences (GILD) continued with its exceptional performance in this quarter as well, beating the Zacks Consensus Estimate
NASDAQ:BIB July 31, 2014 4:23pm

Biotech ETFs To Buy On The Dip [SPDR S&P Biotech (ETF), Gilead Sciences, Inc., iShares NASDAQ Biotechnology Index (ETF)]

biotechnologyThe high flying, and top performing, sector of 2013 – biotech – delivered impressive gains last year, on the back of increasing mergers and acquisition activities, expansion into emerging markets,
NASDAQ:IBB March 31, 2014 10:19pm

ETF Impact On The Biotech Sell-Off [Biogen Idec Inc, Gilead Sciences, Inc., Celgene Corporation, Amgen, Inc.]

biotechnologySweta Killa: The hot and the soaring biotechnology corner of the broad U.S. healthcare market suffered the steepest decline since October 2011 in Friday’s session. The worst sell-off came after U.S. lawmakers raised concerns on Gilead Sciences (NASDAQ:GILD)
NASDAQ:IBB March 24, 2014 4:07pm

Quick Investor Guide To Surging Biotech ETFs [iShares NASDAQ Biotechnology Index (ETF), SPDR S&P Biotech (ETF)]

biotechnologyThe healthcare industry, especially its biotechnology corner, gave an astounding performance last year with the S&P biotechnology select industry index returning about 70%. The performance has been exciting so far this year too, as evident from 15% return
NYSE:BBH February 11, 2014 5:32pm

Time To Take Advantage of the Slaughter in Biotech [NYSE ARCA BIOTECH INDEX, Amgen, Inc.]

biotechnology: At the J.P. Morgan Healthcare Conference in San Francisco three weeks ago, it was all rainbows and unicorns when it came to the biotech sector. At that point, the sector had climbed 50% over the previous year and
NASDAQ:BIB January 31, 2014 2:18pm

Intercept Pharmaceuticals Inc (ICPT) Pushes SPDR Biotech ETF Ahead Of Rivals

biotechnologyIntercept Pharmaceuticals (NASDAQ:ICPT) was a star performer in Thursday’s trading session, as the stock skyrocketed close to 300% on the day. This massive gain for this biotech firm was thanks to some very positive news regarding a trial for the
NASDAQ:IBB January 10, 2014 2:50pm

Are Biotech ETFs Back On Track?

biotechnologyThe healthcare industry, especially its biotechnology corner, has been a great performer so far this year as evident from an impressive 43.64% gain in S&P biotechnology select industry index in the last one year (as of November 25, 2013). The credit for this bull run
NASDAQ:IBB December 3, 2013 6:37pm

How To Play The Bullish Trend In Healthcare With ETFs

healthcare-etfsWhile there have been a series of volatility-inducing events in the U.S. starting from the Fed’s ‘Taper Talk’ and then the tussle between the Republicans and the Democrats, investors have still remained relatively bullish and have put capital
NYSE:BBH November 1, 2013 1:57pm

Highly Ranked Market Vectors Biotech ETF (BBH) In Focus

in focus spotlightLately, investors have begun to move away from sectors which offered higher dividends with lower risk towards risk prone sectors. In fact, some low risk investors who were playing a safe game in the bond markets have also started to give up on fixed income.
NYSE:BBH October 28, 2013 12:50pm

Can The Run Continue For Biotech ETFs?

biotechnologyBiotechnology firms are among the fasting growing companies in the health care world. With the U.S. market soaring, a high growth and high beta sector like biotech is performing remarkably well, clearly outpacing the overall market
NASDAQ:IBB October 23, 2013 6:00pm

Investing In Biotech With Index-Crushing Performance

biotechnologyGreg Madison: If there's one sector that's primed for explosive growth right now, it's biotechnology.
NASDAQ:IBB August 5, 2013 3:04pm

Why The Future Is Increasingly Bright For Biotech ETFs

biotechnologyStocks were broadly higher to start the second half of the year as markets rose on strong economic data in a few key segments of the economy. While many market sectors participated in the rally, one corner of the market saw especially
NASDAQ:IBB July 3, 2013 11:47am

5 ETFs To Tap The Biotechnology Sector

biotechnologyWith ever-increasing health care spending and insatiable demand for new drugs, the biotechnology sector looks poised for good growth going forward. Furthermore, the U.S. biotech sector represents an attractive investment opportunity thanks
NASDAQ:IBB May 28, 2013 2:56pm

Get Free Updates

Join over 50,000 investors who get the latest news from!

Most Popular

From Our Partners

Explore More from

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again! respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories